Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
Wenyuan Xiao,Alejandro Pinilla-Baquero,John Faulkner,Xuehong Song,Pradeep Prabhakar,Hong Qiu,Kelley W. Moremen,Andreas Ludwig,Peter J. Dempsey,Parastoo Azadi,Lianchun Wang
DOI: https://doi.org/10.1038/s41598-022-08227-8
IF: 4.6
2022-03-14
Scientific Reports
Abstract:Abstract Roundabout 4 (Robo4) is a transmembrane receptor that expresses specifically in endothelial cells. Soluble Robo4 was reported in the human plasma and mouse serum and is inhibitory towards FGF- and VEGF-induced angiogenesis. It remains unknown how soluble Robo4 is generated and if soluble Robo4 regulates additional angiogenic signaling. Here, we report soluble Robo4 is the product of constitutive ectodomain shedding of endothelial cell surface Robo4 by disintegrin metalloproteinases ADAM10 and ADAM17 and acts to inhibit angiogenic Slit3 signaling. Meanwhile, the ligand Slit3 induces cell surface receptor Robo4 endocytosis to shield Robo4 from shedding, showing Slit3 inhibits Robo4 shedding to enhance Robo4 signaling. Our study delineated ADAM10 and ADAM17 are Robo4 sheddases, and ectodomain shedding, including negative regulation by its ligand Slit3, represents a novel control mechanism of Robo4 signaling in angiogenesis.
multidisciplinary sciences
What problem does this paper attempt to address?